Log in  First Connection?


Bystander Effects and Profibrotic Interactions in Hepatic Stellate Cells during HIV and HCV Coinfection
 5 min.

 Published on 23/05/2024 |  Original article (Full-text)  | Cevallos Cintia et al. | Journal of Immunology Research 2024 (2024), Article ID 6343757, 14 pages

Due to a common transmission route involving infected human blood, coinfections of the HCV and human immunodeficiency virus (HIV) are relatively prevalent, with an estimated 2.3 million individuals globally living with HCV/HIV coinfection [1]. Numerous studies have evidenced that HIV infection expedites...

The prevalence of major depressive disorder in people with HIV: Results from the All of Us Research Program
 3 min.

 Published on 16/05/2024 |  Original article (Full-text)  | Joshua J. Matacotta et al. | HIV Medicine 2024; AOP: 10.1111/hiv.13653

HIV is a well‐established determinant of mental health concerns across the lifespan, and depression is common in people with HIV. Research gaps on HIV and depression persist despite increased clinical and epidemiological attention to this comorbidity and the suspected role of complex interactions...

Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain
 6 min.

 Published on 09/05/2024 |  Original article (Full-text)  | Josep M. Llibre et al. | HIV Medicine 2024; AOP: 10.1111/hiv.13650

In 2022, the reported number of people with HIV worldwide was 39.0 million (2.3 million from Western/Central Europe and North America) [1], and HIV was recognized as one of the most common reasons for a person to become immunocompromised [2]. Virological failure with emerging resistance...

Telemedicine in HIV health care during the COVID‐19 pandemic: An implementation research study in Buenos Aires, Argentina
 5 min.

 Published on 02/05/2024 |  Original article (Full-text)  | Manuela Bullo et al. | HIV Medicine 2024; AOP: 10.1111/hiv.13646

The COVID‐19 pandemic resulted in almost 696 million infections and 6.9 million deaths worldwide and more than 10 million cases and 130 000 deaths in Argentina by September 2023 [1]. As such, it placed enormous strain on healthcare systems worldwide, with healthcare providers primarily focused...

Epidemiology and characteristics of Paget's disease of bone in a French nationwide HIV cohort
 2 min.

 Published on 25/04/2024 |  Original article (Full-text)  | Blot-Cossard, Amanda et al. | AIDS 2024; 38(6): 929-31

PDB is the second most common metabolic bone disease after osteoporosis [1,2]. The prevalence of PDB is difficult to estimate accurately, because it depends on the diagnostic criteria used. Indeed, PDB can be asymptomatic with variable delayed symptoms, and is typically diagnosed through elevated alkaline...